CBD & Insomnia: What the Latest Research Actually Says (2024-2026)

If you've ever lain awake at 2am with a racing mind, you're not alone. Insomnia affects an estimated one in three adults — and millions have turned to CBD for relief. But what does the science actually say? Here's a comprehensive look at the latest research from 2024 to 2026.

How CBD May Help You Sleep: The Mechanisms

CBD doesn't work like a traditional sleeping pill. Instead of sedating you, it may remove the neurological friction that keeps your brain stuck in a wakeful, stressed state — particularly for people whose insomnia is driven by anxiety or an overactive nervous system.

1. Cortisol & Stress Reduction

Research suggests CBD may lower cortisol by downregulating the gene responsible for corticotropin-releasing hormone (CRH) — a primary chemical signal keeping the nervous system alert. At larger doses (300–600mg), a sedative effect has also been observed. (Source: The Canna Company, 2026; Zebra CBD, 2025)

2. Multi-System Anxiety Modulation

CBD works across multiple anxiety-relevant neural systems simultaneously: it enhances 5-HT1A serotonin receptor signaling, modulates GABA-A receptor function, reduces amygdala hyperreactivity via CB1 receptors, and suppresses HPA axis overactivity by reducing cortisol synthesis. This makes it uniquely positioned to address anxiety — a major driver of sleeplessness. (Source: PMC Scoping Review PMC12695116, 2025)

3. Endocannabinoid System & Sleep Architecture

The endocannabinoid system (ECS) regulates sleep, mood, inflammation, and stress response. CBD modulates ECS signaling through multiple receptor sites. Unlike THC — which may initially help but disrupts sleep architecture long-term — CBD shows promise for improving sleep quality without psychoactive effects. (Source: Cannabinoids and Sleep: Exploring Biological Mechanisms, PMC11011314, 2024)

What Clinical Trials Actually Show

2024 RCT: 150mg CBD for Moderate–Severe Insomnia

A 2024 randomized, placebo-controlled pilot trial published in the Journal of Clinical Sleep Medicine (Narayan et al.) gave 150mg CBD nightly to people with moderate-to-severe insomnia using a double-blind parallel design. Sleep-onset latency and wake-after-sleep-onset did not differ significantly from placebo. However, the CBD group reported greater well-being scores throughout the trial and showed superior objective sleep efficiency after 2 weeks — suggesting CBD's primary impact may be psychological rather than architectural. (Reference: J Clin Sleep Med. 2024;20(5):753–763. DOI: 10.5664/jcsm.10998)

2025 CBD + Terpene Randomized Trial

A 2025 RCT tested 300mg CBD combined with eight terpenes in 125 people with diagnosed insomnia over four weeks. Using wrist-worn sleep trackers, researchers found the CBD-terpene blend increased slow-wave and REM sleep by 1.3% compared to placebo. People with low baseline deep sleep responded better, as did day sleepers vs. night sleepers. (Source: The Marijuana Herald, September 2025)

Stress Reduction — Seven Clinical Trials (PMC Review)

A systematic review published on PMC analyzed seven double-blind, placebo-controlled trials of CBD for stress across 232 participants. All seven showed CBD significantly reduced the stress response and was non-inferior to pharmaceutical comparators. The review also noted that over 10% of the population uses CBD, with 90% finding it effective for stress relief. (Reference: Enhancing Endocannabinoid Control of Stress with CBD, PMC8704602, 2021)

2026 High-Density EEG Study

A 2026 pilot RCT published in the Journal of Sleep Research (McCartney et al.) used high-density EEG in people with insomnia. Results showed cannabinoids reduced cortical hyperarousal during lighter sleep stages while disrupting deeper and REM sleep. A single oral dose reduced total sleep time and REM sleep without impairing next-day alertness. The authors noted that REM sleep disruption is a recognized hallmark of insomnia. (Reference: J Sleep Research, 35(1), e70124, 2026. DOI: 10.1111/jsr.70124)

Large Case Series: Anxiety & Sleep

In a large case series (Shannon et al., The Permanente Journal, 2019), nearly 80% of participants reported reduced anxiety within a month of CBD use, and over 65% reported improved sleep initially. CBD appeared to reduce hyperalertness and overarousal by calming amygdala and hypothalamus activity. (Reference: Shannon S. et al., The Permanente Journal, 2019, 23:18-041)

The Dosage Problem: Lab vs. Real World

One of the most important gaps in CBD sleep research is dosage. Trials showing anxiety and sleep improvements used 25–150mg+. Trials showing cortisol reduction and sedative effects used 300–600mg. Most consumer CBD products deliver only 10–25mg per serving — explaining why real-world effects can feel more subtle. A 2024 systematic review confirmed potential improvements across 18–800mg of CBD, but no consensus exists on optimal dosing guidelines. (Reference: Narayan et al., Psychopharmacology, 2024. DOI: 10.1007/s00213-024-06674-x)

CBD vs. CBN for Sleep: An Emerging Distinction

Recent science is drawing an important line between CBD and CBN (cannabinol) for sleep. CBD's sleep benefits appear to work primarily through anxiety and stress reduction — it removes the obstacle to sleep. CBN acts more directly on sleep architecture.

CBN Research Breakthrough (2024–2025)

A landmark study from the University of Sydney's Lambert Initiative — published in Neuropsychopharmacology (2025) — provided the first objective polysomnography-measured evidence that CBN increases sleep. CBN increased both NREM and REM sleep, boosting total sleep time. Lead researcher Professor Jonathon Arnold noted the effect was comparable to zolpidem (a prescription sleep drug) — without intoxication. (Reference: Arnold J. et al., Neuropsychopharmacology, 50:586–595, 2025. DOI: 10.1038/s41386-024-02018-7)

A double-blind RCT of 321 poor sleepers (Bonn-Miller et al., 2024) found 20mg CBN nightly significantly reduced nighttime awakenings and overall sleep disturbance compared to placebo, with no daytime fatigue impact. Adding CBD did not further improve results over CBN alone. (Reference: Experimental and Clinical Psychopharmacology, 32:277–284, 2024)

In a large 1,000+ participant trial, 50mg CBN showed sleep improvements statistically equivalent to 4mg of melatonin, with a similar safety profile. (Source: The Canna Company, April 2026; Kolobaric A. et al., Pharmaceuticals, 17:977, 2024)

Summary: What the Research Tells Us

CBD is most effective for anxiety-driven insomnia — helping people fall asleep by reducing mental noise, elevated cortisol, and stress-induced arousal. CBN shows stronger direct evidence for improving sleep architecture and reducing nighttime awakenings. Higher doses (150mg+) are generally needed for objective improvements in trials, while lower doses may still help subjectively. Combining CBD and CBN may address different aspects of the sleep problem. Both show consistently mild side effects across studies.

Disclaimer

This article is for informational purposes only and is not intended as medical advice. Consult your healthcare provider before starting any CBD or cannabinoid supplement, especially if you take prescription medications.

References

1. McCartney D. et al. (2026). Acute Effects of Oral Cannabinoids on Sleep and High-Density EEG in Insomnia. Journal of Sleep Research, 35(1), e70124. DOI: 10.1111/jsr.70124

2. Narayan A. et al. (2024). Cannabidiol for moderate-severe insomnia: RCT of 150mg nightly dosing. J Clin Sleep Med, 20(5):753-763. DOI: 10.5664/jcsm.10998

3. Narayan A. et al. (2024). Effect of nightly 150mg CBD on daytime neurocognitive performance in primary insomnia. Psychopharmacology. DOI: 10.1007/s00213-024-06674-x

4. Bonn-Miller M.O. et al. (2024). Safety and effects of CBN with/without CBD on sleep quality. Experimental and Clinical Psychopharmacology, 32:277-284.

5. Arnold J. et al. (2025). CBN and sleep architecture. Neuropsychopharmacology, 50:586-595. DOI: 10.1038/s41386-024-02018-7

6. PMC (2021). Enhancing Endocannabinoid Control of Stress with CBD. PMC8704602. pmc.ncbi.nlm.nih.gov/articles/PMC8704602/

7. PMC Scoping Review (2025). Cannabinoids for Anxiety and Sleep Disturbances. PMC12695116. pmc.ncbi.nlm.nih.gov/articles/PMC12695116/

8. PMC Review (2024). Cannabinoids and Sleep: Biological Mechanisms. PMC11011314. ncbi.nlm.nih.gov/pmc/articles/PMC11011314/

9. Shannon S. et al. (2019). CBD in Anxiety and Sleep: A Large Case Series. The Permanente Journal, 23:18-041.

10. Kolobaric A. et al. (2024). RCT: TruCBN vs melatonin for sleep. Pharmaceuticals, 17:977.